GFC-301

N/A

Report date: 2024/10/16 16:14:46

Base Information

Drug NameGFC-301
Drug Alias NameGFC301
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionA disintegrin and metalloproteinase with thrombospondin motifs 4 inhibitors
TargetsA disintegrin and metalloproteinase with thrombospondin motifs 4
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeneFrontier Corp
China Registration ClassN/A

Develop Information

Active CompaniesGeneFrontier Corp
Inactive CompaniesN/A
Active IndicationsOsteoarthritisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A